"RP-3467, our potential best-in-class Polθ ATPase inhibitor, has demonstrated highly compelling preclinical results, ...
An innovative new database, the Open Source Munitions Portal (OSMP), identifies and shows remnants of explosive devices in ...
Researchers have developed a breakthrough technology that uses light to visualize nanoscale glass microcapillary tips, ...
Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with common diseases, ...
Stratasys Ltd. (NASDAQ: SSYS) today announced the launch of its TechStyleâ„¢ Fabric Alignment Station, the next milestone in the evolution of Stratasys 3DFashionâ„¢ technology. This solution is designed ...
Developing therapeutic products that not only treat cancer but also enable oncology patients to maintain uninterrupted therapy.Expanding its ...
CHICAGO, Oct. 1, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will expand its suite of Nikkei 225 futures contracts with the addition of yen- and U.S ...
Developing therapeutic products that not only treat cancer but also enable oncology patients to maintain uninterrupted therapy.Expanding its pipeline to include non-oncology products, an opportunistic ...
The Spider Demon Mother from Demon Slayer left an indelible mark on the series, not just as a formidable antagonist, but as ...
America leads the OECD’s projection of member country economies, with 2.6 percent growth anticipated for 2024, while the Euro ...
Following the completion of the 2024 drill program, the Company has executed several exploration related activities, including utilizing machine learning from a World View III alteration study, a ...